DelveInsight Business Research Press Releases - EIN Presswire

Published on July 11, 2024 - 10:30 GMT

Fibromyalgia Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Fibromyalgia companies are Eli Lilly, Sun Pharmaceutical Industries Ltd., Intec Pharma Ltd., Aptinyx Prismic Pharmaceuticals, Astellas Pharma Inc., and others. LAS VEGAS, NEVADA, UNITED STATES, July 11, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 11, 2024 - 07:30 GMT

Leigh Syndrome Market Report 2034: Epidemiology, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Leigh Syndrome companies are NV354, and others. LAS VEGAS, NEVADA, UNITED STATES, July 11, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Leigh Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 16:45 GMT

Cocaine Intoxication Market Report 2034: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Cocaine Intoxication companies are Tonix Pharmaceutical, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Cocaine Intoxication Market Insights, Epidemiology, and Market Forecast-2034″ report offers an …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 15:45 GMT

Burn Pain Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Burn Pain companies are Takeda, Amgen, Novartis, AVEO Pharmaceuticals, Inc., Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Burn Pain …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 15:00 GMT

Atherosclerotic Cardiovascular Disease Market Report 2034: Epidemiology, Therapies, Latest Approvals by DelveInsight

Atherosclerotic Cardiovascular Disease companies are Amgen Inc., Novo Nordisk A/S, NewAmsterdam Pharma, CSL Behring, BMS, Silence Therapeutics Plc, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 14:30 GMT

Multiple System Atrophy Market Report 2032: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Multiple System Atrophy companies are Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Multiple …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 14:00 GMT

Multiple Sclerosis Market Report 2034: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, Bayer, Novartis, Biogen, Genentech, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Multiple …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 12:30 GMT

Fibrodysplasia Ossificans Progressiva Market Forecast 2032: FDA Approvals, Clinical Trials, & Companies by DelveInsight

The Fibrodysplasia Ossificans Progressiva market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. ALBANY, NEW YORK, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 12:30 GMT

Dry Eye Disease Market Forecast 2032: FDA Approvals, Clinical Trials, Pipeline, Therapies, and Companies by DelveInsight

The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. ALBANY, NEW YORK, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Dry Eye Disease Market Insights …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 12:30 GMT

Eosinophilic Esophagitis Market Forecast 2034: FDA Approvals, Clinical Trials, Therapies, and Companies by DelveInsight

According to DelveInsight, the Eosinophilic Esophagitis Market size was valued ~ USD 940 thousand million in 2023. ALBANY, NEW YORK, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Eosinophilic Esophagitis Market Insights, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 12:30 GMT

Hand Eczema Market Forecast 2032: FDA Approvals, Clinical Trials, Pipeline, Therapies, and Companies by DelveInsight

The Hand Eczema market size was approximately USD 11.5 billion in 2022, analyses DelveInsight. ALBANY, NEW YORK, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Hand Eczema Market Insights, Epidemiology, and Market Forecast-2032″ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 12:00 GMT

Multiple Myeloma Market Report 2034: Epidemiology, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Multiple Myeloma companies are BMS, Cartesian Therapeutics, AstraZeneca, Abbvie (Pharmacyclics), Johnson & Johnson, MorphoSys AG/I-Mab Biopharma, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 10:45 GMT

Onychomycosis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Onychomycosis companies are Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer, Bausch Health, Sato Pharmaceutical, Eisai, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Onychomycosis Market Insights …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 09:45 GMT

Opioid Use Disorder Market Report 2034: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Opioid Use Disorder companies are Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Opioid Use …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 09:00 GMT

Oncolytic Virus Cancer Therapy Pipeline Report 2024: Companies, Therapies, Latest FDA, EMA, Approvals by DelveInsight

Companies working in the Oncolytic Virus Cancer Therapy segment are GeneMedicine, Oncolys BioPharma, SillaJen Biotherapeutics, Turnstone Biologics, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 08:30 GMT

Fuchs Endothelial Corneal Dystrophy Market Report 2034: Epidemiology Data, Therapies, Latest Approvals by DelveInsight

Fuchs Endothelial Corneal Dystrophy companies are Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Fuchs Endothelial Corneal Dystrophy Market Insights, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 10, 2024 - 06:10 GMT

Opioid Withdrawal Syndrome Market Report 2034: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Opioid Withdrawal Syndrome companies are atai Life Sciences, Medicinova, BioXcel Therapeutics Inc., and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Opioid Withdrawal Syndrome Market Insights, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 9, 2024 - 17:33 GMT

Recurrent or Metastatic Head and Neck Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals

Recurrent or Metastatic Head and Neck Cancer Pipeline DELHI, DELHI, INDIA, July 9, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s, "Recurrent or Metastatic Head and Neck cancer Pipeline Insight 2024” report provides comprehensive insights about 40+ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 9, 2024 - 17:22 GMT

HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals

HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline DELHI, DELHI, INDIA, July 9, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Insight 2024” report provides comprehensive insights about 5+ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 9, 2024 - 16:58 GMT

ER+/ HER2 -ve Breast Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals

ER+/ HER2 -ve Breast Cancer Pipeline DELHI, DELHI, INDIA, July 9, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “ER+/ HER2-VE Breast Cancer Pipeline Insight 2024” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in ER+/ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...